Colofiore Jr. et al., PHARM RES (1989 Oct.) 6(10) 863-6 Applicant should supply a copy of this reference. |
Colofiore et al., Pharmaceutical Research Official Journal of the American Association of Pharmaceutical Scientists, vol. 6, No. 10, pp. 863-866, Oct. 1989. |
Yip et al., Biochemical Pharmacology, vol. 36, No. 5, pp. 633-637, Mar. 1, 1987. |
Martin et al, "Use of Oral Uridine as a Substitute for Parenteral Uridine Rescue of 5-Fluorouracil Therapy, With and Without the Uridine Phosphorylase Inhibitor 5-Benzylacyclouridine", Cancer Chemotherapy and Pharmacology, 24, 1989, pp. 9-14. |
Darnowski et al, "Tissue-specific Enhancement of Uridine Utilization and 5-Fluorouracil Therapy in Mice by Benzylacyclouridine", Cancer Research, vol. 45, Nov. 1985, pp. 5364-5368. |
Groeningen et al, "Clinical and Pharmacokinetic Studies of Prolonged Administration of High-Dose Uridine Intended for Rescue From 5-FU Toxicity", Cancer Treatment Reports, vol. 70, No. 6, Jun. 1986, pp. 745-750. |
Groeningen et al, "Reversal of 5-Fluorouracil Induced Myelosuppression by Prolonged Administration of High-Dose Uridine", Reports, Journal of the National Cancer Institute, vol. 81, No. 2, Jan. 18, 1989, p. 157. |